We use cookies for a better user experience. Read our Privacy Policy

I Agree

Infection Prevention Devices Market

Infection Prevention Devices Market (Product: Infection Prevention Supplies, Medical Waste Disposable Devices, Infection Prevention Equipment; End User: Hospitals, Lifescience Industries, Clinical Laboratories, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027

Infection Prevention Devices Market: Proliferation of Antibiotic Resistance and Hospital-associated Infections to Propel Adoption

Modern patients have expressed their beliefs in prevention, rather than cure, in a bid to minimize healthcare expenses and boost overall health. Owing to this, most bioengineering efforts need to be directed to the level of prevention, thereby enhancing patient care. Another factor driving the need for the prevention of diseases and infections is antibiotic resistance, which is a globally-rising issue. Moreover, the slow-paced and complex development of new antibiotics is decreasing the healthcare sector’s arsenal of existing drugs, posing a severe threat as ordinary infections become difficult to treat.

As the fight for endurance continues, infection prevention is becoming a vital aspect. With the escalating aggregation of antimicrobial resistance, the healthcare sector has to revert back to the very basics of infection control; develop, evaluate, and implement sets of prevention methods. Transparency Market Research (TMR), in its recent publication on the infection prevention devices market, uncovers the essentials of the industry, with focus on the indications showcasing developments in the market.

infection prevention devices market success strategies of manufacturers

Identify the key factors that will drive your company’s growth. Request a brochure of this report here 

History Paves the Way for the Future

Scientific study of nosocomial or hospital cross-infection commenced in the early 18th century, followed by the start of the 'Bacteriological Era', which marked the development of new methods of investigating disease outbreaks. The actual understanding of hospital infection was with the discoveries of Pasteur, Koch, and Lister, along with the beginning of the Bacteriological Era. The 19th century seemed to herald the final victory over hospital cross-infection, and witnessed the successes of hospital asepsis and reform. However, this victory was momentary, as it was discovered that, the occurrence of infections was not only in surgical and obstetric patients but also in medical patients, and that air could be a source of infection. Followed by this, the causes of hospital infections along with antibiotic-resistant organisms garnered attention.

Infection prevention and control evolved over time, bringing modern practices into the spotlight. Modern healthcare underwent significant transformations over the years, adopting a proactive approach over the conventionally in-practice, reactive approach. Infection prevention and control took a quantum leap with the emergence of infection control devices, further supported by continued developments and improvisations. The infection prevention devices market is expected to hold a value of ~ US$ 16.9 Bn in 2019, with gains banking on the increasing number of surgical procedures and growing incidents of chronic diseases.

Want to know more such detailed insights of “Infection Prevention Devices Market”? Request a PDF sample here

Key Trends Impacting Market Growth

Rising Geriatric Population to Create Opportunities

The rising geriatric population and increasing incidences of chronic diseases among the older population are creating opportunities for infection prevention devices market players, as hospital admissions continue to rise. Combating hospital-associated infections is becoming a crucial part of patient care, directing attention towards next-gen infection prevention devices.

Growing Antibiotic Resistance to Bolster Demand

Although healthcare continues to develop, emerging organisms are becoming stronger and more immune to antibiotics. Antibiotic resistance is emerging as a global health issue. Alternative measures include innovative antibiotics, which would be expensive, or the usage of phage therapy. On account of this, infection prevention and control remains the most sought-after way to combat this health concern.

Evolving Hospital-level Care in Other Environments

The emergence of personalized patient care, and establishment of urgent care clinics and primary care clinics are reflecting the expansion of patient-care across hospital levels. Organizations following this path require infection prevention supplies and equipment to minimize or eradicate the spread of pathogens. The establishment of such mobile and efficient clinical care centers is likely to create major demand for infection prevention devices.

Infection prevention devices continue to gain momentum across a number of end uses, and the increasing number of surgeries continues to offer growth potential for this business. However, as the healthcare sector continues to develop, next-gen therapeutics and treatments are being provided to patients, resulting in reduced hospital stay, thereby minimizing the need for infection prevention devices. This could hinder the growth of the infection prevention devices market.

infection prevention devices market

Expanding operations in future? To get the perfect launch ask for a custom report here

Success Strategies of Manufacturers

Leverage Ultraviolet Technology

With the rise in antibiotic-resistant bacteria and virulent viruses over the last couple of years, healthcare professionals are analyzing their infection prevention methods and adopting newer, improved alternatives that promote better methods of disinfection. One such technique is the ultraviolet infection prevention technology. A new study shows that, ultraviolet disinfection technology eliminates nearly 98 percent of pathogens in the operating room, and might also help defeat superbugs. The implementation of this technique in next-gen infection prevention devices would help providers gain greater margins in sales.

Introduce Advanced Products

Research and development remains a vital strategy for key infection prevention devices market players. Key investments are made for enhancing R&D capabilities in a bid to introduce newer and advanced products to gain a strong market position. Moreover, key research activities are being focused primarily on improving patient outcomes and minimizing failure rates in patients with infectious diseases.

Strengthen Distribution in the U.S.

North America has showcased major growth opportunities for the injection prevention devices market. Continued developments in healthcare and advancements in technologies that support enhanced patient care witnessed across the U.S. are creating major demand for infection prevention and control techniques. Strengthening distribution across North America could allow companies to churn greater profits.

Analysis of the Competitive Landscape

In 2018, Coloplast A/S acquired IncoCare Gunhild Vieler GmbH, a German direct-to-consumer homecare company, to strengthen its position in Germany. Coloplast and IncoCare plan to bring innovative products and services to more consumers across the country.

In 2019, Hollister Incorporated launched the Infyna Chic intermittent catheter, the latest in its line of female hydrophilic catheter offerings. This new catheter is designed to help provide women who use catheters with a high level of discretion. This product would be added to the complete Infyna portfolio, offering women a variety of options to meet their individual needs.

Mölnlycke Health Care AB and Zuellig Pharma entered into a partnership to focus on offering advanced wound care products and solutions to healthcare practitioners and patients across Southeast Asia.

Companies operating in the infection prevention devices market continue to invest in research and development to offer end users with advanced infection prevention supplies. With the support of infection tracking software and AI-enabled systems, infection prevention devices market players are able to offer improved product capabilities. Collaborations and partnerships in a bid to expand both, product portfolio and distribution, are majorly considered.

infection prevention devices market segmentation

Analysts’ Perspective on the Market

TMR analysts have a positive perspective on the infection prevention devices market on account of various factors driving the applicability of these devices. According to the analysts, the launch of specifically-designed and advanced infection prevention supplies will push the infection prevention devices market onto a growth trajectory in the coming years. North America remains a prominent market for infection prevention devices, offering sales opportunities for leading market players. Companies aiming geographical expansions could consider business avenues in the U.S. The demand for infection prevention devices continues to grow in hospitals, especially in developed countries, where patient care remains a point of focus for healthcare professionals. Owing to this, hospitals, along with emerging clinical care centers, continue to offer significant sales opportunities for market players. New market entrants could capitalize on this opportunity by offering specifically-designed infection prevention devices for hospitals.

Global Infection Prevention Devices Market: Overview

The global infection prevention devices market was valued at ~ US$ 15.4 Bn in 2018. It is projected to expand at a CAGR of 6.0% from 2019 to 2027. Increase in the global geriatric population, rise in hospital admissions and outpatient visits, and increased demand for infection prevention products due to surgical procedures are key factors that are fueling the global infection prevention devices market.

  • Healthcare-associated infections (HAIs) are infections that are acquired in healthcare facilities or as a result of healthcare interventions, and are a major issue for patient safety. Hand hygiene is a highly effective means of preventing HCAIs.
  • The employer, in cases of HAIs, should introduce reasonable measures to minimize the risk of employees acquiring or spreading infection. In addition to GPs and practice nurses, administrative and cleaning staff can be exposed to communicable diseases and / or blood / bodily fluid exposure, and therefore, should be vaccinated as appropriate.
  • HAIs are infections that are acquired in healthcare facilities or as a result of healthcare interventions, and are a major problem for patient safety.
  • Personal protective equipment (PPE) refers to a range of barriers and respirators used alone or in combination to protect mucous membranes, airways, skin, and clothing from contact with infectious agents. The selection of protective equipment required depends on an assessment of the risk of transmission of microorganisms to the patient, and the risk of contamination of the healthcare practitioner’s clothing and skin by a patient’s blood, body fluids, secretions, or excretions.
  • Potential sources of pathogens in general practice include bacteria, viruses, pathogenic fungi, protozoa, worms, and prions. Every interaction in general practice should include a risk assessment of the potential for infection transmission.

Drivers & Restraints: Global Infection Prevention Devices Market

  • The geriatric population is increasing at a faster rate than that of the younger population. This leads to an increase in hospital visits and surgical procedures, which, in turn, drives the demand for laboratory testing. These factors are likely to propel the global infection prevention devices market. The present geriatric population of 962 million is around 13% of the global population, and is increasing at a rate of around 3% every year. Furthermore, the number of persons aged 80 years or above is estimated to be triple by 2050, an increase from 137 million in 2017 to 425 million by 2050.
  • Rise in hospital admissions and outpatient visits could drive the market, thereby fuelling the preference for outpatient care, as it is cost-effective and does not require hospital stay. This is a key factor that is likely to drive the market. Chronic wounds may lead to frequent visits to the hospital or nearby clinic. The number of people with chronic diseases continues to increase globally, and hence, most of them require surgeries.
  • The emergency care services of NHS and several other health systems are coming under great strain, and our research has shown that, a significant factor in this rise in emergency admissions is due to the improvement in survival rates at hospitals. This has led to a higher number of people being admitted for unplanned, emergency care for subsequent admissions.
  • Technological advancements and drug innovation resulting in minimal hospital stay are expected to restrain the infection prevention devices market. Infection prevention helps improve the mobility of patients, and has proven to be beneficial, owing to several features.
  • A visit to the hospital is mostly a last resort for patients, due to the costs associated with admittance. The opportunity for unrelated infections developing in hospitals and other healthcare facilities is high due to the invasive nature of several modern medical procedures.
  • The number of surgeries performed in recent decades has increased, exposing patients to infections at incision sites. Moreover, numerous diagnostic instruments and other medical devices are utilized in the treatment of diseases. It is more critical than ever for hospitals to ensure that infectious diseases do not spread.

Market Segmentation: Global Infection Prevention Devices Market

  • The global infection prevention devices market has been segmented based on product, end user, and region
  • In terms of product, the global infection prevention devices market has been classified into infection prevention supplies, medical waste disposable devices, and infection prevention equipment.
  • The infection prevention supplies segment dominated the global infection prevention devices market in 2018, and is projected to continue its dominance during the forecast period.
  • Based on end user, the global infection prevention devices market has been divided into hospitals, lifescience industries, clinical laboratories, and others. The hospitals segment dominated the global infection prevention devices market in 2018, due to an increase in global admittance of the geriatric population in hospitals and laboratories for the diagnosis of old age-related diseases.

Regional Segmentation: Global Infection Prevention Devices Market

  • In terms of region, the global infection prevention devices market has been segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
    • North America
      • North America dominated the global infection prevention devices market in 2018 due to a rise in hospital admissions in the region.
      • Moreover, outpatient visits and increased demand for infection prevention products due to surgical procedures drives the demand for lifescience reagents.
    • Europe
      • The infection prevention devices market in Europe is anticipated to expand at a considerable growth rate in the near future, owing to the presence of a large geriatric population and well-established market players in the region.
    • Asia Pacific
      • The global infection prevention devices market in Asia Pacific is projected to expand at a high CAGR during the forecast period, due to a large patient pool and increasing investments in healthcare in countries such as China.

Major Players: Global Infection Prevention Devices Market

Key players operating in the global infection prevention devices market include

  • Johnson & Johnson (DePuy Synthes)
  • Cardinal Health
  • PAUL HARTMANN AG
  • Mölnlycke Health Care AB
  • 3M Healthcare
  • B. Braun Melsungen AG
  • Coloplast Group
  • Ethicon, Inc. (Johnson & Johnson)
  • Medline Industries, Inc.
  • Becton
  • Dickinson and Company
  • C. R. Bard, Inc. (Becton, Dickinson and Company)
  • Hollister Incorporated.

These players are adopting strategies such as new product development, partnerships, and acquisitions to remain competitive in the global infection prevention devices market.

Infection Prevention Devices Market Taxonomy

Product

Infection Prevention Supplies

Medical Waste Disposable Devices

Infection Prevention Equipment

End User

Hospitals

Lifescience Industries

Clinical Laboratories

Others

Region

North America

Europe

Asia Pacific

Latin America

Middle East & Africa

Infection Prevention Devices Market

Interested in this report?
Get a FREE Brochure now!

Get Free Brochure

*Get Brochure Report (PDF) sent to your email within minutes

Frequently Asked Questions

What is the total market worth of infection prevention devices market?

Infection prevention devices market to Reach ~US$ 25.7 Bn by 2027

What is the anticipated CAGR of the infection prevention devices market in the forecast period?

Infection prevention devices market is projected to expand at a CAGR of 6.0% from 2019 to 2027

What are the key driving factors for the growth of the infection prevention devices market?

Infection prevention devices market is driven by increase in the global geriatric population and rise in hospital admissions and outpatient visits

Which region is expected to project the highest market share in the global infection prevention devices market?

North America accounted for a major share of the global infection prevention devices market

Who are the key players in the infection prevention devices market?

Key players in the infection prevention devices market include Johnson & Johnson (DePuy Synthes), Cardinal Health, PAUL HARTMANN AG, Mölnlycke Health Care AB, 3M Healthcare

1. Preface
    1.1. Market Definition and Scope
    1.2. Market Segmentation
    1.3. Key Research Objectives
    1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Infection Prevention Devices Market
4. Market Overview

    4.1. Introduction
        4.1.1. Type Definition
        4.1.2. Industry Evolution / Developments
    4.2. Overview
    4.3. Market Dynamics
        4.3.1. Drivers
        4.3.2. Restraints
        4.3.3. Opportunities
    4.4. Global Infection Prevention Devices Market Analysis and Forecast, 2017–2027
        4.4.1. Market Revenue Projections (US$ Mn
5. Market Outlook
    5.1. Regulatory Scenario by Region/Globally
    5.2. Reimbursement Scenario by Region/Globally
6. Global Infection Prevention Devices Market Analysis and Forecast, by Product
    6.1. Introduction & Definition
    6.2. Key Findings / Developments
    6.3. Global Infection Prevention Devices Market Forecast, by Product, 2017–2027
        6.3.1. Infection Prevention Supplies
        6.3.2. Infection Prevention Services
        6.3.3. Infection Prevention Equipment
    6.4. Global Infection Prevention Devices Market Attractiveness, by Type
7. Global Infection Prevention Devices Market Analysis and Forecast, by End-user
    7.1. Introduction & Definition
    7.2. Key Findings / Developments
    7.3. Global Infection Prevention Devices Market Forecast, by End-user, 2017–2027
        7.3.1. Hospitals
        7.3.2. Lifescience Industries
        7.3.3. Clinical Laboratories
        7.3.4. Others
    7.4. Global Infection Prevention Devices Market Attractiveness, by End-user
8. Global Infection Prevention Devices Market Analysis and Forecast, by Region
    8.1. Key Findings
    8.2. Global Infection Prevention Devices Market Forecast, by Region
        8.2.1. North America
        8.2.2. Europe
        8.2.3. Asia Pacific
        8.2.4. Latin America
        8.2.5. Middle East & Africa
    8.3. Global Infection Prevention Devices Market Attractiveness, by Region
9. North America Infection Prevention Devices Market Analysis and Forecast
    9.1. Introduction
        9.1.1. Key Findings
    9.2. North America Infection Prevention Devices Market Forecast, by Product, 2017–2027
        9.2.1. Infection Prevention Supplies
        9.2.2. Infection Prevention Services 
        9.2.3. Infection Prevention Equipment
    9.3. North America Infection Prevention Devices Market Forecast, by End-user, 2017–2027
        9.3.1. Hospitals
        9.3.2. Lifescience Industries
        9.3.3. Clinical Laboratories
        9.3.4. Others
    9.4. North America Infection Prevention Devices Market Forecast, by Country, 2017–2027
        9.4.1. U.S.
        9.4.2. Canada
    9.5. North America Infection Prevention Devices Market Attractiveness Analysis
        9.5.1. By Type
        9.5.2. By End-user
        9.5.3. By Country
10. Europe Infection Prevention Devices Market Analysis and Forecast
    10.1. Introduction
        10.1.1. Key Findings
    10.2. Europe Infection Prevention Devices Market Forecast, by Product, 2017–2027
        10.2.1. Infection Prevention Supplies
        10.2.2. Infection Prevention Services
        10.2.3. Infection Prevention Equipment
    10.3. Europe Infection Prevention Devices Market Forecast, by End-user, 2017–2027
        10.3.1. Hospitals
        10.3.2. Lifescience Industries
        10.3.3. Clinical Laboratories
        10.3.4. Others
    10.4. Europe Infection Prevention Devices Market Forecast, by Country/Sub-region, 2017–2027
        10.4.1. Germany
        10.4.2. U.K.
        10.4.3. France
        10.4.4. Spain
        10.4.5. Italy
        10.4.6. Rest of Europe
    10.5. Europe Infection Prevention Devices Market Attractiveness Analysis
        10.5.1. By Type
        10.5.2. By End-user
        10.5.3. By Country/Sub-region
11. Asia Pacific Infection Prevention Devices Market Analysis and Forecast
    11.1. Introduction
        11.1.1. Key Findings
    11.2. Asia Pacific Infection Prevention Devices Market Forecast, by Product, 2017–2027
        11.2.1. Infection Prevention Supplies
        11.2.2. Infection Prevention Services
        11.2.3. Infection Prevention Equipment
    11.3. Asia Pacific Infection Prevention Devices Market Forecast, by End-user, 2017–2027
        11.3.1. Hospitals
        11.3.2. Lifescience Industries
        11.3.3. Clinical Laboratories
        11.3.4. Others
    11.4. Asia Pacific Infection Prevention Devices Market Forecast, by Country/Sub-region, 2017–2027
        11.4.1. China
        11.4.2. Japan
        11.4.3. India
        11.4.4. Australia & New Zealand
        11.4.5. Rest of Asia Pacific
    11.5. Asia Pacific Infection Prevention Devices Market Attractiveness Analysis
        11.5.1. By Type
        11.5.2. By End-user
        11.5.3. By Country/Sub-region
12. Latin America Infection Prevention Devices Market Analysis and Forecast
    12.1. Introduction
        12.1.1. Key Findings
    12.2. Latin America Infection Prevention Devices Market Forecast, by Product, 2017–2027
        12.2.1. Infection Prevention Supplies
        12.2.2. Infection Prevention Services
        12.2.3. Infection Prevention Equipment
    12.3. Latin America Infection Prevention Devices Market Forecast, by End-user, 2017–2027
        12.3.1. Hospitals
        12.3.2. Lifescience Industries
        12.3.3. Clinical Laboratories
        12.3.4. Others
    12.4. Latin America Infection Prevention Devices Market Forecast, by Country, 2017–2027
        12.4.1.  Brazil
        12.4.2. Mexico
        12.4.3. Rest of Latin America
    12.5. Latin America Infection Prevention Devices Market Attractiveness Analysis
        12.5.1. By Type
        12.5.2. By End-user
        12.5.3. By Country/Sub-region
13. Middle East & Africa Infection Prevention Devices Market Analysis and Forecast
    13.1. Introduction
        13.1.1. Key Findings
    13.2. Middle East & Africa Infection Prevention Devices Market Forecast, by Product, 2017–2027
        13.2.1. Infection Prevention Supplies
        13.2.2. Infection Prevention Services
        13.2.3. Infection Prevention Equipment
    13.3. Middle East & Africa Infection Prevention Devices Market Forecast, by End-user, 2017–2027
        13.3.1. Hospitals
        13.3.2. Lifescience Industries
        13.3.3. Clinical Laboratories
        13.3.4. Others
    13.4. Middle East & Africa Infection Prevention Devices Market Forecast, by Country/Sub-region, 2017–2027
        13.4.1. GCC Countries
        13.4.2. South Africa
        13.4.3. Israel
        13.4.4. Rest of Middle East & Africa
    13.5. Middle East & Africa Infection Prevention Devices Market Attractiveness Analysis
        13.5.1. By Type
        13.5.2. By End-user
        13.5.3. By Country/Sub-region
14. Competition Landscape
    14.1. Market Player – Competition Matrix (By Tier and Size of companies)
    14.2. Market Share Analysis By Company (2019)
    14.3. Company Profiles
        14.3.1. Johnson & Johnson
        14.3.2. Cardinal Health
        14.3.3. PAUL HARTMANN AG
        14.3.4. Mölnlycke Health Care AB
        14.3.5. 3M Healthcare
        14.3.6. B. Braun Melsungen AG
        14.3.7. Coloplast Group
        14.3.8. Ethicon, Inc.
        14.3.9. Medline Industries, Inc.
        14.3.10. C. R. Bard, Inc.
        14.3.11. Hollister Incorporated
        14.3.12. Danaher Corporation
        14.3.13. Other Prominent Key Players
15. Assumptions and Acronyms Used
16. Research Methodology

List of Tables

Table 01: Global Infection Prevention Devices Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 02: Global Infection Prevention Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 03: Global Infection Prevention Devices Market Value (US$ Mn) Forecast, by Region, 2017–2027
Table 04: North America Global Infection Prevention Devices Market Value (US$ Mn) Forecast, by Country, 2017–2027
Table 05: North America Global Infection Prevention Devices Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 06: North America Global Infection Prevention Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 07: U.S. Global Infection Prevention Devices Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 08: U.S. Global Infection Prevention Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 09: Canada Global Infection Prevention Devices Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 10: Canada Global Infection Prevention Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 11: Europe Global Infection Prevention Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 12: Europe Global Infection Prevention Devices Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 13: Europe Global Infection Prevention Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 14: U.K. Global Infection Prevention Devices Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 15: U.K. Global Infection Prevention Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 16: Germany Global Infection Prevention Devices Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 17: Germany Global Infection Prevention Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 18: France Global Infection Prevention Devices Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 19: France Global Infection Prevention Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 20: Italy Global Infection Prevention Devices Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 21: Italy Global Infection Prevention Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 22: Spain Global Infection Prevention Devices Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 23: Spain Global Infection Prevention Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 24: Asia Pacific Global Infection Prevention Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 25: Asia Pacific Global Infection Prevention Devices Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 26: Asia Pacific Global Infection Prevention Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 27: China Global Infection Prevention Devices Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 28: China Global Infection Prevention Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 29: India Global Infection Prevention Devices Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 30: India Global Infection Prevention Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 31: Japan Global Infection Prevention Devices Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 32: Japan Global Infection Prevention Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 33: Australia & New Zealand Global Infection Prevention Devices Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 34: Australia & New Zealand Global Infection Prevention Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 35: Latin America Global Infection Prevention Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 36: Latin America Global Infection Prevention Devices Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 37: Latin America Global Infection Prevention Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 38: Brazil Global Infection Prevention Devices Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 39: Brazil Global Infection Prevention Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 40: Mexico Global Infection Prevention Devices Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 41: Mexico Global Infection Prevention Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 42: Middle East & Africa Global Infection Prevention Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 43: Middle East & Africa Global Infection Prevention Devices Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 44: Middle East & Africa Global Infection Prevention Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 45: GCC Global Infection Prevention Devices Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 46: GCC Global Infection Prevention Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 47: South Africa Global Infection Prevention Devices Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 48: South Africa Global Infection Prevention Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2027

List of Figures 

Figure 01: Global Infection Prevention Devices Market Snapshot
Figure 02: Global Infection Prevention Devices Market Segments with Leading Market Share (%), 2017
Figure 03: Global Infection Prevention Devices Market Value (US$ Mn) Forecast, 2017?2027
Figure 04: Global Infection Prevention Devices Market Value Share (%), by Product (2019)
Figure 05: Global Infection Prevention Devices Market Value Share (%), by End-user (2019)
Figure 06: Global Infection Prevention Devices Market Value Share (%), by Region (2019)
Figure 07: Global Infection Prevention Devices Market Value Share Analysis, by Product, 2019 and 2027
Figure 08: Global Infection Prevention Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Infection Prevention Supplies, 2017–2027
Figure 09: Global Infection Prevention Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Medical Waste Disposable Devices, 2017–2027
Figure 10: Global Infection Prevention Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Infection Prevention Equipment, 2017–2027
Figure 11: Global Infection Prevention Devices Market Attractiveness, by Product, 2019–2027
Figure 12: Global Infection Prevention Devices Market Value Share (%), by End-user, 2017 and 2027
Figure 13: Global Infection Prevention Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Hospitals, 2017–2027
Figure 14: Global Infection Prevention Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Lifescience Industries, 2017–2027
Figure 15: Global Infection Prevention Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Clinical Laboratories, 2017–2027
Figure 16: Global Infection Prevention Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Others, 2017–2027
Figure 17: Global Infection Prevention Devices Market Attractiveness, by End-user, 2019–2027
Figure 18: Global Infection Prevention Devices Market Value Share Analysis, by Region 2019 and 2027
Figure 19: Global Infection Prevention Devices Market Attractiveness, by Region, 2019–2027
Figure 20: North America Infection Prevention Devices Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 201–2027
Figure 21: North America Infection Prevention Devices Market Value Share (%), by Product, 2019 and 2027
Figure 22: North America Infection Prevention Devices Market Attractiveness, by Product, 2019–2027
Figure 23: North America Infection Prevention Devices Market Value Share (%), by End-user, 2019 and 2027
Figure 24: North America Infection Prevention Devices Market Attractiveness, by End-user, 2019–2027
Figure 25: North America Infection Prevention Devices Market Value Share (%), by Country/Sub-region, 2019 and 2027
Figure 26: North America Infection Prevention Devices Market Attractiveness, by Country/Sub-region, 2019–2027
Figure 27: Europe Infection Prevention Devices Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027
Figure 28: Europe Infection Prevention Devices Market Value Share (%), by Product, 2017 and 2027
Figure 29: Europe Infection Prevention Devices Market Attractiveness, by Product, 2019–2027
Figure 30: Europe Infection Prevention Devices Market Value Share (%), by End-user, 2019–2027
Figure 31: Europe Infection Prevention Devices Market Attractiveness, by End-user, 2019–2027
Figure 32: Europe Infection Prevention Devices Market Value Share (%), by Country/Sub-region, 2019 and 2027
Figure 33: Europe Infection Prevention Devices Market Attractiveness, by Country/Sub-region, 2019–2027
Figure 34: Asia Pacific Infection Prevention Devices Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027
Figure 35: Asia Pacific Infection Prevention Devices Market Value Share (%), by Product, 2019 and 2027
Figure 36: Asia Pacific Infection Prevention Devices Market Attractiveness, by Product, 2019–2027
Figure 37: Asia Pacific Portable Oxygen Concentrators Share (%), by End-user, 2019 and 2027
Figure 38: Asia Pacific Infection Prevention Devices Market Attractiveness, by End-user, 2019–2027
Figure 39: Asia Pacific Infection Prevention Devices Market Value Share (%), by Country/Sub-region, 2019 and 2027
Figure 40: Asia Pacific Infection Prevention Devices Market Attractiveness, by Country/Sub-region, 2019–2027
Figure 41: Latin America Infection Prevention Devices Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027
Figure 42: Latin America Infection Prevention Devices Market Value Share (%), by Product, 2019 and 2027
Figure 43: Latin America Infection Prevention Devices Market Attractiveness, by Product, 2019–2027
Figure 44: Latin America Infection Prevention Devices Market Share (%), by End-user, 2019 and 2027
Figure 45: Latin America Infection Prevention Devices Market Attractiveness, by End-user, 2019–2027
Figure 46: Latin America Infection Prevention Devices Market Value Share (%), by Country/Sub-region, 2017 and 2027
Figure 47: Latin America Infection Prevention Devices Market Attractiveness, by Country/Sub-region, 2019–2027
Figure 48: Middle East & Africa Infection Prevention Devices Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027
Figure 49: Middle East & Africa Infection Prevention Devices Market Value Share (%), by Product, 2019 and 2027
Figure 50: Middle East & Africa Infection Prevention Devices Market Attractiveness, by Product, 2019–2027
Figure 51: Middle East & Africa Infection Prevention Devices Market Share (%), by End-user, 2017 and 2027
Figure 52: Middle East & Africa Infection Prevention Devices Market Attractiveness, by End-user, 2019–2027
Figure 53: Middle East & Africa Infection Prevention Devices Market Value Share (%), by Country/Sub-region, 2019 and 2027
Figure 54: Middle East & Africa Infection Prevention Devices Market Attractiveness, by Country/Sub-region, 2019–2027
Figure 55: Global Infection Prevention Devices Market Share Analysis, by Company (2019)

Transparency Market Research Plus
  • We offer 100% free customisation with our Enterprise License!!
  • Get a free copy if the report you purchased is updated within 90 days
  • Regardless from where you have purchased the report, you can request an updated version of the report from us.

Complete the form below and we'll get back to you shortly.

293

Your personal details are safe with us. Privacy Policy*

Copyright © Transparency Market Research, Inc. All Rights reserved